HP Pyruvate MRI in Cancers
Hyperpolarized 13-C Pyruvate MRI Surveillance of Multiple Cancers
University of Maryland, Baltimore
25 participants
Jun 24, 2024
INTERVENTIONAL
Conditions
Summary
Many human diseases are characterized by their ability to alter existing metabolic pathways and interrupt cellular processes. Cancer exploits the Warburg effect and utilizes greater glucose than normal cells and within this process uses anaerobic respiration, leading to increased conversion of pyruvate to lactate. This can be exploited by hyperpolarized imaging. Hyperpolarized 13C MRI imaging is an approach that utilizes a stable isotope of Carbon (13C) linked to pyruvate. MRI spectroscopy is used in conjunction with hyperpolarized 13C pyruvate in order to temporally detect pyruvate and its conversion to lactate in-vivo, in order to visualize downstream metabolic (glycolytic) activity secondary to the Warburg effect, which should be useful in detecting and characterizing tumors of various types. Hyperpolarized 13C pyruvate MR imaging has not been tested in most cancers. In this preliminary survey, we will test the hypothesis that hyperpolarized 13C pyruvate MR imaging can be used to image various cancers.
Eligibility
Inclusion Criteria3
- Clinical tumor diagnosis
- Patients with pre-existing MR imaging appointments
- Must be able to undergo MR
Exclusion Criteria1
- No tumor diagnosis
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Imaging tumors pre and post administration of hyperpolarized 13-C pyruvate injection.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05697406